本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CytoMed Therapeutics Limited

0.9400
-0.0600-6.00%
成交量:1.41萬
成交額:1.32萬
市值:1,111.87萬
市盈率:-3.54
高:1.00
開:1.00
低:0.9300
收:1.00
52周最高:3.68
52周最低:0.6801
股本:1,182.84萬
流通股本:349.43萬
量比:0.72
換手率:0.40%
股息:- -
股息率:- -
每股收益(TTM):-0.2657
每股收益(LYR):-0.2657
淨資產收益率:-50.28%
總資產收益率:-29.31%
市淨率:2.16
市盈率(LYR):-3.54

資料載入中...

2026/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/31

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/20

SEC問詢函

Form CORRESP - Correspondence
2025/04/28

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/23

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/22

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/15

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/19

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/05/01

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/04/24

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals